Stempeutics
Akshay Tech Park
#72 & 73, 2nd Floor, EPIP Zone, Phase 1,
Whitefield
Bangalore
560066
Tel: 91-80-39992400
Fax: 91-80-39992402
Website: http://www.stempeutics.com/
Email: info@stempeutics.com
5 articles about Stempeutics
-
Cipla and Stempeutics collaborate for launch of Stempeucel®, first 'Made in India' Cell Therapy to treat Critical Limb Ischemia (CLI)
8/21/2020
Developed by Stempeutics over a period of twelve years, breakthrough treatment designed to address root cause of the disease at an affordable cost
-
Stempeutics Release: DCGI Gives Limited Approval To Market FIRST Allogeneic Cell Therapy Product In India Stempeutics Puts India On The 'World Map Of Regenerative Medicine'
5/31/2016
-
Stempeutics Receives Japan Process Patent For Its Novel Stem Cell Drug 'Stempeucel'
6/8/2015
-
Stempeutics Receives Orphan Drug Designation (ODD) In The European Union For Its Novel Stem Cell Drug "Stempeucel" For The Treatment Of Thromboangiitis Obliterans
6/1/2015
-
Stempeutics Receives Advanced Therapy Medicinal Product (ATMP) Classification From European Medicines Agency For Its Novel Stem Cell Drug 'Stempeucel'
3/23/2015